Prior PCa Tx does not preclude abiraterone use.
| Publicado en: | Urology Times Vol. 39; no. 12; p. 29 |
|---|---|
| Autor principal: | |
| Formato: | brief item pictorial Journal Article |
| Publicado: |
MJH Life Sciences
Nov2011
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=67306547&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 67306547 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00939722 URO jtl: Urology Times issn: 00939722 maglogo: N pubinfo: dt: Nov2011 vid: 39 iid: 12 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 67306547 67306547 108226556 67306547 ppf: 29 ppct: 0 formats: fmt: @attributes: type: P tig: atl: Prior PCa Tx does not preclude abiraterone use. aug: au: Krader, Cheryl Guttman sug: subj: Prostatic Neoplasms Drug Therapy Androstenedione Administration and Dosage Male Protocols Male pubtype: Academic Journal doctype: brief item pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|